£35 means we can empower more people living with HIV to challenge stigma with our information workshops, videos and broadcasts. Lipodystrophy is a side-effect of some anti-HIV drugs. These are mainly ...

AIDS Rev. 2008;10(3):152-161. In patients with HIV-related lipodystrophy (assessed by patients and confirmed by physicians), Marin, et al. have recently validated a new questionnaire consisting of ...

have evaluated the safety and efficacy of polyalkylimide gel (PAIG) in the treatment of HIVassociated facial lipoatrophy in a randomized, openlabel, single-centre study. Thirty-one HIV-infected ...

Novelion Therapeutics’ Myalepta (metreleptin) developed for the ultra-rare condition lipodystrophy has been approved by the European Commission, giving patients the first treatment to improve ...

The findings reported by the researchers answer some of the questions as to why patients receiving successful treatment for HIV end up with abnormal fat loss and deposits – a problem call ...

Gilead Sciences, GSK, ViiV Healthcare 1 to 3 years In June 2024, results from a trial of a new medicine to prevent HIV were announced—and they were jaw-dropping. Lenacapavir, a treatment ...

PHILADELPHIA (KYW Newsradio) — Medications that help prevent HIV are under a microscope, as researchers look at just how much impact a change in their cost would create. The University of ...

F8 formulation intended to replace EGRIFTA SV ® with simplified dosing for the treatment of excess abdominal fat in adults with HIV and lipodystrophy MONTREAL, Nov. 26, 2024 (GLOBE NEWSWIRE) — ...

Morningstar brands and products Company Portfolio ...